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High  Resolution  CT
scan
Abstract  The  diagnosis  of  diffuse  parenchymal  lung  disease  (DPLD)  may  require  invasive  pro-
cedures after  all  noninvasive  tools  have  failed.  The  clinical  context  in  which  these  diseases
develop  and  the  radiological  patterns  are  crucial  for  deﬁning  the  timing  and  the  methods  to  be
used. After  the  introduction  in  clinical  practice  of  HRCT  scan,  the  evaluation  of  imaging  pat-
terns, along  with  the  immunological  status  of  the  patient  and  the  clinical  course  of  the  disease
(acute vs.  chronic)  seem  to  be  crucial  to  choose  the  best  diagnostic  procedure.





Doenc¸a  difusa  do
parênquima
pulmonar;
A  biópsia  pulmonar  transbrônquica  para  o  diagnóstico  de  doenc¸a difusa  do
parênquima  pulmonar;  Pro
Resumo  O  diagnóstico  de  doenc¸a  difusa  do  parênquima  pulmonar  (DDPP)  pode  necessitar
de procedimentos  invasivos  caso  todas  as  técnicas  não  invasivas  tenham  falhado.  O  contexto
clínico no  qual  estas  doenc¸as  se  desenvolvem  e  os  padrões  radiológicos  são  importantes  para
a deﬁnic¸ão  de  tempo  e  métodos  a  serem  utilizados.  Após  a  introduc¸ão  na  prática  clínica  daPlease  cite  this  article  in  press  as:  Casoni  GL,  et  al.  The  trans
lung  disease;  Pro. Rev  Port  Pneumol.  2011.  doi:10.1016/j.rppn
Imagem  de  Alta
Resoluc¸ão TAC de  alta  resoluc¸ão  (HRCT),  a  avaliac¸ão  dos  padrões  de  imagem,  juntamente  com  o  estado
imunológico  do  doente  e  o  curso  clínico  da  doenc¸a  (aguda  vs.  crónica),  revelam-se  importantes
para seleccionar  o  melhor  procedimento  de  diagnóstico.
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direitos reservados.
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he  diagnosis  of  diffuse  parenchymal  lung  disease  (DPLD)
ay  require  invasive  procedures  after  all  noninvasive  tools
ave  failed.  The  clinical  context  in  which  these  diseases
evelop  and  the  radiological  patterns  are  crucial  for  deﬁning





































































































reviewed  22  patients  with  known  UIP  (21  cases  diagnosed  by
surgical  biopsy,  1  case  diagnosed  by  clinical  and  radiologic
features)  and  then  retrospectively  examined  transbronchial
biopsies  (TBLB)  from  these  patients.  They  concluded  thatARTICLEPPNEU-24; No. of Pages 4
 
he  timing  and  the  methods  to  be  used.  After  the  introduc-
ion  in  clinical  practice  of  High  Resolution  CT  scan  (HRCT),
he  evaluation  of  imaging  patterns,  along  with  the  immuno-
ogical  status  of  the  patient  and  the  clinical  course  of  the
isease  (acute  vs.  chronic)  seem  to  be  crucial  in  choosing
he  best  diagnostic  procedure.1,2 In  the  immunocompro-
ised  patients  who  develop  DPLD,  a  prompt  diagnosis  is
ssential  for  a  better  survival.  In  this  circumstance,  bron-
hoalveolar  lavage  (BAL),  especially  when  the  bronchoscope
s  guided  by  HRCT  scan  ﬁndings  performed  a  few  hours
efore,  is  generally  of  value  in  diagnosing  opportunistic
nfections,  alveolar  proteinosis,  alveolar  hemorrhage  and
apillaritis,  lymphomatous  or  leukemic  lung  inﬁltration,
arcinomatous  lymphangitis,  disseminated  hematogenous
ung  metastases,  hypersensitivity  pneumonitis,  eosinophilic
neumonitis  or  diffuse  alveolar  damage  due  to  drugs  or
adiation.  In  these  cases,  when  a  conclusive  diagnosis  is
ot  obtained  by  BAL  ﬂuid  analysis  or  in  most  immuno-
ompetent  patients  who  develop  DPLD,  transbronchial  lung
iopsy  (TBLB)  or  even  open  lung  biopsy  could  be  consid-
red.  The  TBLB  forceps  makes  it  possible  to  obtain  lung
issue  through  the  bronchial  routes  and  the  specimens  so
btained  usually  represent  from  the  centrilobular  regions.3,4
herefore,  the  disorders  that  are  centered  around  termi-
al  and  respiratory  bronchioles  [respiratory  bronchiolitis
RB),  tuberculosis,  lobular  infectious  pneumonia,  cellular
ronchiolitis]  or  signiﬁcantly  involve  these  structures  (orga-
izing  pneumonia)  or  are  distributed  along  the  lymphatic
outes  (sarcoidosis,  carcinomatous  lymphangitis)  may  be
requently  sampled  by  the  forceps.4,5 In  1965,  Andersen  and
olleagues  at  the  Mayo  Clinic  described  for  the  ﬁrst  time
he  rigid  bronchoscopic  technique  of  TBLB6 and  in  the  sub-
equent  trials  they  reported  that  lung  tissue  was  obtained
n  84%  of  patients  with  DPLD  by  using  the  technique  of
BLB.7 The  introduction  of  the  ﬂexible  bronchoscope  in
he  late  1960s  increased  the  popularity  of  the  technique
nd  demonstrated  that  TBLB  with  the  ﬂexible  instrument
ay  be  obtained  with  minimal  mortality  and  morbidity.  Cur-
ently  TBLB  is  a  well-established  diagnostic  technique  used
y  almost  all  bronchoscopists,  and  the  ﬂexible  bronchoscope
s  used  almost  exclusively.  The  main  complication  of  TBLB
s  bleeding;  less  frequent  complications  are  pneumothorax,
ypoxemia,  or  cardiac  arrhythmias  during  the  procedure.
leeding  occurs  to  some  degree  in  virtually  all  TBLB  proce-
ures  and  it  is  the  main  limiting  factor  in  obtaining  more
r  larger  biopsy  samples.  Bleeding  is  a  major  concern  to
he  bronchoscopist  because  of  the  limited  options  available
o  manage  excessive  bleeding  through  the  ﬂexible  broncho-
cope.  The  suction  channel  of  the  typical  bronchoscope  is
nly  2  mm  in  diameter,  and  the  volume  of  blood  that  can
e  suctioned  through  the  channel  is  therefore  limited.  How-
ver,  to  minimize  the  consequence  of  hemorrhage  by  TBLB,
t  is  possible  to  perform  the  procedure  using  the  rigid  bron-
hoscopy  and  placing  a  non  inﬂated  Fogarty  balloon  and  a
igid  aspirator  (4  mm  in  diameter)  in  lobar  bronchus  near
he  biopsy  segment.  The  Fogarty  balloon  can  be  promptly
nﬂated  in  case  of  bleeding.  In  this  way  it  is  much  easier
o  control  the  bleeding  complications.8,3 The  main  utility  ofPlease  cite  this  article  in  press  as:  Casoni  GL,  et  al.  The  trans
lung  disease;  Pro. Rev  Port  Pneumol.  2011.  doi:10.1016/j.rppn
he  TBLB  rests  in  the  possibility  of  making  a  speciﬁc  diag-
osis  in  a  patient  with  DPLD  and  avoiding  a  surgical  lung
iopsy.  Some  studies  have  demonstrated  that  the  morpho-
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such  as  in  the  diagnosis  of  idiopathic  interstitial  pneumonia)
ppeared  to  have  little  relevance  to  subsequent  clini-
al  course.9 While  the  monomorphous  histological  patterns
organizing  pneumonia,  eosinophilic  pneumonia,  diffuse
lveolar  damage  with  or  without  eosinophils,  alveolar  hem-
rrhage  with  or  without  capillaritis,  alveolar  proteinosis)
re  easily  identiﬁable  in  small  lung  fragments  (but  only
n  agreement  with  clinical,  radiological  and  other  lab-
ratory  data),4,10 the  tiny  specimens  obtained  by  TBLB
ay  not  be  sufﬁcient  to  deﬁne  the  histological  pattern
usual  interstitial  pneumonitis,  desquamative  interstitial
neumonitis,  nonspeciﬁc  interstitial  pneumonitis,  ﬁbros-
ng  type).  However,  from  the  morphological  point  of  view,
enerous  TBLB  may  also  provide  good  specimens  for  a  diag-
osis  of  a  pattern  called  nonspeciﬁc  interstitial  pneumonia
NSIP),  cellular  variant  in  speciﬁc  clinical  settings  such  as
olymyositis-dermatomyositis-related  interstitial  lung  dis-
ase,  drug  toxicity  ore  in  cases  of  unknown  etiology11
lthough  surgical  lung  biopsy  is  considered  the  best  way  to
btain  enough  tissue  to  demonstrate  this  pattern.  The  ques-
ion  of  which  kind  of  biopsy  should  be  performed  to  diagnose
PLD  has  a  long  and  controversial  history.  Certainly,  the  sur-
ical  lung  biopsy  provides  substantially  more  material  for
athological  study,  but  the  procedure  requires  general  anes-
hesia,  and  one  or  more  days  in  the  hospital  with  a  chest
ube  in  place.  Moreover,  some  reports  have  shown  that  this
urgical  procedure  may  be  associated  with  increased  mor-
ality  in  certain  states  of  the  disease.  In  the  experience  of
any  interstitial  lung  disease  centers  across  the  world  the
edian  mortality  is  4-6%  within  30  days  following  surgical
ung  biopsy  for  UIP12,13 but  biopsy  performed  at  the  time  of
cute  exacerbation  (AE)  resulted  in  higher  30-day  mortality
28.6%)  compared  to  non-AE.14 Therefore,  in  recent  years
ome  studies  have  sought  to  increase  the  diagnostic  yield
f  transbronchial  lung  biopsy  in  diagnosis  of  DPLD  to  avoid
he  surgical  lung  biopsy.  In  this  respect,  Berbescu  et  al15bonchial  lung  biopsy  for  diagnosis  of  diffuse  parenchymal
eu.2011.05.003
igure  1  Transbronchial  lung  biopsy.  Diagnosis:  Carcinomato-
us lymphangitis  due  to  gastric  adenocarcinoma.  The  lymphatics
re dilated  and  surrounded  by  neoplastic  acini.  Pulmonary
rtery neoplastic  microangiopathy  is  also  present.
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sFigure  2  Transbronchial  lung  biopsy.  Intraalveolar  ﬁbrotic  bud
typically  observed  in  cryptogenetic  organizing  pneumonia.
a  diagnosis  of  UIP  was  possible  on  the  TBLB  in  seven  sub-
jects,  and  in  two  others  that  the  ﬁndings  were  consistent
with  UIP.  As  a  rationale  for  the  use  of  TBLB,  the  authors
reported  the  high  mortality  within  30  days  following  surgi-
cal  lung  biopsy  for  UIP.  However  in  a  critical  editorial  Churg
and  Schwarz  dampened  this  enthusiasm  and  suggested  that
‘‘the  collective  wisdom  be  followed  and  that  TBLB  should
not  be  used  to  diagnose  IPF/UIP’’  because  the  morpho-
logic  ﬁndings  of  interstitial  inﬂammation  and  ﬁbrosis  in  TBLB
appeared  to  have  little  relevance  to  the  subsequent  clini-
cal  course.16 However  that  has  not  stopped  the  tenacity  of
other  researchers  in  assessing  the  improved  diagnostic  yield
using  non-surgical  methods  for  the  histological  diagnosis  of
ﬁbrosing  diffuse  lung  disease.  In  a  study,8 we  reported  a  sig-
niﬁcant  diagnostic  yield  and/or  better  preserved  specimens
(Fig.  1,  2)  when  TBLB  were  performed  under  general  anes-Please  cite  this  article  in  press  as:  Casoni  GL,  et  al.  The  trans
lung  disease;  Pro. Rev  Port  Pneumol.  2011.  doi:10.1016/j.rppn
thesia  with  rigid  bronchoscope  using  larger  forceps  (called
Jumbo  forceps)  (Fig.  3)  and  without  pulling  them  through  the
biopsy  channel.  Then  a  new  way  of  obtaining  TBLB  using  ﬂex-





Figure  4  (a)  A  ﬂexible  cryoprobe  is  shown.  The  metal  tip,  can  be
biopsy obtained  by  ﬂexible  cryoprobes  with  lung  sample  attached
specimens showing  a  bronchiole  and  lung  parenchyma  (interstitial  inigure  3  Jumbo  forcep  with  a  lung  sample  that  is  poured  out
f the  tip  of  the  forceps.
ryosurgical  equipment  operates  by  the  Joule-Thompson
ffect,  which  dictates  that  a  compressed  gas  released  at
igh  ﬂow  rapidly  expands  and  creates  a  very  low  tempera-
ure.  The  advantage  of  the  cryoprobe  is  that  large  pieces  of
issue  can  be  extracted  with  the  freeze-thaw  cycle.  The  ﬁrst
ublished  data17,18 indicate  that,  especially  in  idiopathic
nterstitial  pneumonia,  transbronchial  cryobiopsy  could  add
mportant  information.  The  size  of  the  samples  obtained
eems  to  increase  the  diagnostic  yield  signiﬁcantly  com-bonchial  lung  biopsy  for  diagnosis  of  diffuse  parenchymal
eu.2011.05.003
ared  to  forceps  biopsies.  Transbronchial  cryobiopsies  are
uch  larger  than  conventional  forceps  biopsies  but  smaller
han  surgical  lung  biopsies.  Despite  having  a  potentially
arge  defect  in  the  lung  parenchyma,  the  occurrence  of
 visualized  under  ﬂuoroscopic  control.  (b)  Transbronchial  lung
 to  the  metal  tip.  (c)  Hematoxylin  Eosin  (low  power).  Large
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neumothorax  and  bleeding  was  low  compared  to  data  from
orceps  biopsies.  These  data,  therefore,  indicate  that  the
BLB  may  have  even  greater  potential  role  in  the  diagnostic
lgorithm  of  DLDL  (even  in  its  ﬁbrosing  variants).
Furthermore,  when  TBLB  was  introduced  into  clinical
ractice,  a  positive  biopsy  by  the  TBLB  technique  was
eﬁned  as  diagnostic  histology,  histology  that  supported  a
iagnosis,  or  histology  consistent  with  the  ﬁnal  diagnosis.
ndeed,  most  of  the  published  reports  have  focused  on  the
iagnostic  accuracy  of  histologic  analysis  of  TBLB  in  patients
ith  diffuse  lung  disorders.  In  contrast  there  were  no  data
n  how  TBLB  results  are  used  by  clinicians.  In  a  very  interest-
ng  study,  Ensminger  and  Prakash19 evaluated  if  the  results
f  the  TBLB  were  clinically  useful  in  the  management  of
atients  with  diffuse  pulmonary  disorders.  In  the  study  TBLB
as  considered  useful  if:  (a)  it  resulted  in  a  speciﬁc  clini-
al  diagnosis,  (b)  a  speciﬁc  management  decision  was  made
ased  on  the  biopsy  result,  or  (c)  certain  pathologic  pro-
esses  were  excluded  on  the  basis  of  the  biopsy  result  and
ther  clinical  information.  The  results  indicated  that  TBLB  is
 clinically  useful  test  in  approximately  75%  of  procedures,
ertainly  not  a  negligible  percentage.
In  view  of  the  above  data,  we  believe  that  the  use  of  TBLB
n  the  diagnosis  of  DLDL  is  useful  and  safe,  but  certainly  still
oo  underestimated  and  undervalued  by  most  clinicians.  We
elieve  that  a  future  topic  in  the  study  of  DPLD  should  be  a
reater  implementation  of  the  techniques  of  immunohisto-
hemistry,  molecular  biology  and  microarray  to  be  applied
ven  on  tiny  samples  obtained  from  the  TBLB  to  increase
he  diagnostic  yield  and  reduce  the  need  to  refer  to  surgical
ung  biopsy  for  diagnosis.
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